BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22513409)

  • 1. Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin.
    Watanabe H; Noguchi T; Miyamoto Y; Kadowaki D; Kotani S; Nakajima M; Miyamura S; Ishima Y; Otagiri M; Maruyama T
    Drug Metab Dispos; 2012 Jul; 40(7):1423-8. PubMed ID: 22513409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate.
    Viaene L; Annaert P; de Loor H; Poesen R; Evenepoel P; Meijers B
    Biopharm Drug Dispos; 2013 Apr; 34(3):165-75. PubMed ID: 23300093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
    Huang WH; Hung CC; Yang CW; Huang JY
    Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
    Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
    Lin CJ; Wu V; Wu PC; Wu CJ
    PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.
    Li J; Wang Y; Xu X; Cao W; Shen Z; Wang N; Leng J; Zou N; Shang E; Zhu Z; Guo J; Duan J
    Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
    Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
    Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Uremic Toxins on the Binding of Aripiprazole to Human Serum Albumin.
    Nishi K; Sakurama K; Watanabe H; Maruyama T; Yamasaki K; Otagiri M
    Biol Pharm Bull; 2021; 44(3):437-441. PubMed ID: 33642552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
    Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
    Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney.
    Miyamoto Y; Watanabe H; Noguchi T; Kotani S; Nakajima M; Kadowaki D; Otagiri M; Maruyama T
    Nephrol Dial Transplant; 2011 Aug; 26(8):2498-502. PubMed ID: 21303967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
    Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
    Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the binding properties of the uremic toxin phenylacetic acid to human serum albumin.
    Saldanha JF; Yi D; Stockler-Pinto MB; Soula HA; Chambert S; Fouque D; Mafra D; Soulage CO
    Biochimie; 2016 Jun; 125():53-8. PubMed ID: 26945842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.
    Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A
    NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin.
    Sakai T; Yamasaki K; Sako T; Kragh-Hansen U; Suenaga A; Otagiri M
    Pharm Res; 2001 Apr; 18(4):520-4. PubMed ID: 11451040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.
    Hsu HJ; Yen CH; Chen CK; Wu IW; Lee CC; Sun CY; Chang SJ; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
    Gen Hosp Psychiatry; 2013; 35(1):23-7. PubMed ID: 23044245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.